sal0120
sal0120: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: West Pharmaceutical Services Inc. (WST)
Development Pipeline (1)
| Company | Phase |
|---|---|
| West Pharmaceutical Services Inc. (WST) | Phase 2 |
Clinical Trials (1)
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Trial Evaluating the Efficacy and Safety of SAL0120 Tablets in Patients With Chronic Kidney Disease (CKD).
Frequently asked questions
Who is developing sal0120?
sal0120 is being developed by West Pharmaceutical Services Inc..
How many clinical trials involve sal0120?
BioSniper tracks 1 clinical trial involving sal0120.
Analyze West Pharmaceutical Services Inc. & sal0120 with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company